Table 1.

Effect of srhCD40L on Proliferation and the Induction of Apoptosis of Human Breast Carcinoma Cell Lines

Cell Line Treatment CPM (±SD) NMP (U/mL)
MDA-231 (CD40+)  —  14,567 (216)  <2 
 srhCD40L (1 μg/mL)  6,875 (158) 26* 
 srhCD40L (1 μg/mL)  9,778 (364)* 18* 
 Anti-fas (10 ng/mL)  5,098 (206) 38* 
T47D (CD40+)  —  37,658 (1,897)  
 srhCD40L (10 μg/mL)  22,592 (2,025)* 36* 
 srhCD40L (1 μg/mL)  27,798 (2,046)* 27* 
 Anti-fas (10 μg/mL)  11,674 (1,923) 58* 
MCF-7 (CD40)  —  19,867 (1,216)  0  
 srhCD40L (10 μg/mL) 18,976 (321)  0  
 srhCD40L (1 μg/mL) 20,981 (1,786)  0  
 Anti-fas (10 μg/mL) 7,930 (483) 37* 
Cell Line Treatment CPM (±SD) NMP (U/mL)
MDA-231 (CD40+)  —  14,567 (216)  <2 
 srhCD40L (1 μg/mL)  6,875 (158) 26* 
 srhCD40L (1 μg/mL)  9,778 (364)* 18* 
 Anti-fas (10 ng/mL)  5,098 (206) 38* 
T47D (CD40+)  —  37,658 (1,897)  
 srhCD40L (10 μg/mL)  22,592 (2,025)* 36* 
 srhCD40L (1 μg/mL)  27,798 (2,046)* 27* 
 Anti-fas (10 μg/mL)  11,674 (1,923) 58* 
MCF-7 (CD40)  —  19,867 (1,216)  0  
 srhCD40L (10 μg/mL) 18,976 (321)  0  
 srhCD40L (1 μg/mL) 20,981 (1,786)  0  
 Anti-fas (10 μg/mL) 7,930 (483) 37* 

Cell lines were incubated for 72 hours with either srhCD40L or anti-fas as indicated in the Methods. Proliferation was assessed by 3H-thymidine incorporation and apoptosis was by NMP levels in the supernatants.

*

P > .05.

P > .01.

Close Modal

or Create an Account

Close Modal
Close Modal